Skip to main content

Toll-Like Receptor 3

  • Reference work entry
  • First Online:
  • 136 Accesses

Synonyms

CD283; CD283 antigen

Historical Background

The innate immune system of mammals is equipped with various kinds of cells, such as macrophages and dendritic cells (DCs), which provides the first line of defense to the host in recognizing various kinds of pathogens. These cells have developed different classes of protein based receptors for recognizing numerous kinds of pathogen associated molecular patterns (PAMPs) (Miggin and O’Neill 2006). These different classes of pathogen recognition receptors (PRRs) includes, Membrane bound PRRs such as Toll-like receptors (TLRs), Receptor kinases, Mannose receptors and Cytoplasmic PRRssuch as Nucleotide oligomerization domain (NOD) receptors, the Retinoic acid inducible gene I (RIG-I)-like receptor (RLR) family, and the recently described AIM2 and DAI cytosolic DNA receptors. All these receptor proteins play a crucial role in “danger” recognition and induction of the innate immune responses against a variety of bacterial and viral...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci USA. 2006;103:8792–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Botos I, Liu L, Wang Y, Segal DM, Davies DR. The toll-like receptor 3:dsRNA signaling complex. Biochim Biophys Acta. 2009;1789:667–74.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol. 2006;7:1074–81.

    Article  PubMed  CAS  Google Scholar 

  • Cheng YS, Xu F. Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol Ther. 2010;10:1219–23.

    Article  PubMed  CAS  Google Scholar 

  • de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem. 2005;280:38133–45.

    Article  PubMed  CAS  Google Scholar 

  • Funami K, Matsumoto M, Oshiumi H, Akazawa T, Yamamoto A, Seya T. The cytoplasmic ‘linker region’ in Toll-like receptor 3 controls receptor localization and signaling. Int Immunol. 2004;16:1143–54.

    Article  PubMed  CAS  Google Scholar 

  • Gauzzi C, Del Corno M, Gessani S. Dissecting TLR3 signaling in dendritic cells. Immunobiology. 2010;215:713–23.

    Article  PubMed  CAS  Google Scholar 

  • Jin B, Sun T, Yu XH, Liu CQ, Yang YX, Lu P, et al. Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant. J Biomed Biotechnol. 2010;2010:690438.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem. 2008;283:3988–96.

    Article  PubMed  CAS  Google Scholar 

  • Kenny EF, Talbot S, Gong M, Golenbock DT, Bryant CE, O’Neill LA. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J Immunol. 2009;183:3642–51.

    Article  PubMed  CAS  Google Scholar 

  • Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J. 2009;420:1–16.

    Article  PubMed  CAS  Google Scholar 

  • Miggin SM, O’Neill LA. New insights into the regulation of TLR signaling. J Leukoc Biol. 2006;80:220–6.

    Article  PubMed  CAS  Google Scholar 

  • Nomura N, Nagase T, Miyajima N, Sazuka T, Tanaka A, Sato S, et al. Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1 (supplement). DNA Res. 1994;1:251–62.

    Article  PubMed  CAS  Google Scholar 

  • Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature. 2006;439:208–11.

    Article  PubMed  CAS  Google Scholar 

  • Sasai M, Tatematsu M, Oshiumi H, Funami K, Matsumoto M, Hatakeyama S, et al. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. Mol Immunol. 2010;47:1283–91.

    Article  PubMed  CAS  Google Scholar 

  • Schröder M, Baran M, Bowie AG. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKe-mediated IRF activation. EMBO J. 2008;27:2147–57.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Siednienko J, Miggin SM. Expression analysis of the Toll-like receptors in human peripheral blood mononuclear cells. Methods Mol Biol. 2009;517:3–14.

    Article  PubMed  CAS  Google Scholar 

  • Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM. TLR3-mediated IFN-beta gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Eur J Immunol. 2010;40:3150–60.

    Article  PubMed  CAS  Google Scholar 

  • Siednienko J, Gajanayake T, Fitzgerald KA, Moynagh P, Miggin SM. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-(beta) and RANTES production. J Immunol. 2011;186:2514–22.

    Article  PubMed  CAS  Google Scholar 

  • Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev. 2008;21:13–25.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yamamoto M, Takeda K. Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract. 2010;2010:240365.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhou Y, Wang X, Liu M, Hu Q, Song L, Ye L, et al. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology. 2010;131:40–9.

    PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sinéad M. Miggin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Butt, A.Q., Miggin, S.M. (2018). Toll-Like Receptor 3. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_607

Download citation

Publish with us

Policies and ethics